Study on the efficacy and mechanism of horticultural therapy combined with intradermal needle for the treatment of generalized anxiety in isolated personnel associated with the COVID-19 outbreak&#
- Conditions
- Generalized anxiety disorder
- Registration Number
- ITMCTR2200006846
- Lead Sponsor
- Shenzhen Bao'an Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
A. Meeting the Chinese and Western medical diagnostic criteria for generalized anxiety disorder.
B. Those with a GAD-7 scale score =5 and <14.
C. Hamilton Anxiety Inventory (HAMA) = 7 and =21.
D. No Chinese or Western medicine medication and psychotherapy, acupuncture treatment and no other trials within the last two months.
E. Patients were conscious, without aphasia or mental retardation, with junior high school education or above, able to understand the content of the scale and cooperate with the treatment.
F. Those who voluntarily participated in this study and signed the informed consent form.
A. Those who have a history of other diseases that can cause anxiety symptoms or with psychotic symptoms before enrollment, such as schizophrenia, mania, etc., and cannot cooperate with the completion of this study.
B. Pregnant and lactating women.
C. Aged less than 18 years or more than 70 years or older.
D. Those with redness, swelling, injury, infection, etc. of the body skin and soft tissues.
E. Clearly combined history of serious other systemic diseases, such as stroke, malignancy, renal failure, diabetes mellitus, cardiac insufficiency and other diseases.
F. Metal allergies to nickel, chromium and other stainless steel components.
G. Those who do not cooperate or reject horticultural therapy and intradermal needle treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in PAS 25 (response cortical LTP effect) and PAS 10 (response cortical LTD effect) in cerebral cortex;Serological indicators(corticotropin-releasing hormone\adrenocorticotropic hormone\plasma corticosterone);Assessment of relevant scales (Hamilton Anxiety Scale, Self-rating Anxiety Scale, Pittsburgh Sleep Quality Index);
- Secondary Outcome Measures
Name Time Method